Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status - A possible element of the extracellular antioxidant defense system

Journal of Nutrition

Volumn 126, Issue 4 SUPPL., 1996, Pages

  Ueland, Per M ^a   Mansoor, M Azam ^b   Guttormsen, Anne B ^a   Müller, Fredrik ^c   Aukrust, Pål ^c   Refsum, Helga ^a   Svardal, Asbjørn M ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b STAVANGER UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

aminothiol compounds; HIV; homocysteine; redox status in plasma; renal failure; vascular disease

Indexed keywords

AMINOTHIOL; ANTIOXIDANT; HOMOCYSTEINE;

AMINO ACID METABOLISM; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG OXIDATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; OXIDATION REDUCTION REACTION; PROTEIN BINDING; VITAMIN DEFICIENCY;

EID: 0029864947     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/126.suppl_4.1281s     Document Type: Conference Paper

References (28)

1. Allen, R. H., Stabler, S. P., Savage, D. G. & Lindenbaum, J. (1994) Metabolic abnormalities in cobalamin (Vitamin-B12) and folate deficiency. FASEB J 7: 1344-1353.
2. Andersson, A., Isaksson, A., Brattstrom, L. & Hultberg, B. (1993) Homocysteine and other thiols determined in plasma by HPLC and thiol-specific postcolumn derivatization. Clin. Chem. 39: 1590-1597.
3. Andersson, A., Lindgren, A. & Hultberg, B. (1995) Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction. Clin. Chem. 41: 361-366.
4. Araki, A., Sako, Y., Fukushima, Y., Matsumoto, M., Asada, T. & Kita, T. (1989) Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. Atherosclerosis 79: 139-146.
5. Baker, D. H. & Wood, R. J. (1992) Cellular antioxidant status and human immunodeficiency virus replication. Nutr. Rev. 50: 15-18.
6. Boushey, C. J., Beresford, S. A. A., Omenn, G. S. & Motulsky, A. G. (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. J. Am. Med. Assoc. 274: 1049-1057.
7. Canestrari, F., Galli, F., Giorgini, A., Albertini, M. C., Galiotta, P., Pascucci, M. & Bossu, M. (1994) Erythrocyte redox state in uremic anemia: effects of hemodialysis and relevance of glutathione metabolism. Acta Haematol. 91: 187-193.
8. Costaglio, C., Romano, L., Sorice, P. & Di Benedetto, A. (1989) Anemia and chronic renal failure: the possible role of the oxidative state of glutathione. Nephron 52: 11-14.
9. Hagelskjaer, L., Rasmussen, K. & Pedersen, K. O. (1991) Patients with human immunodeficiency virus infection have normal concentration of methylmalonic acid in serum. Am. J. Hematol. 37:139 (lett.).
10. Halliwell, B. (1994) Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344: 721-724.
11. Halliwell, B. & Gutteridge, J. M. C. (1990) The antioxidants of human extracellular fluids. Arch. Biochem. Biophys. 280: 1-8.
12. Herbert, V., Fong, W., Gulle, V. & Stopler, T. (1990) Low holotranscobalamin-II is the earliest serum marker for subnormal vitamin-B12 (cobalamin) absorption in patients with AIDS. Am. J. Hematol. 34: 132-139.
13. Hultberg, B., Andersson, A. & Amadottir, M. (1995) Reduced, free and total fractions of homocysteine and other thiol compounds in plasma from patients with renal failure. Nephron 70: 62-67.
14. Jacobsen, D. W., Green, R., Herbert, V., Longworth, D. L. & Rehm, S. (1990) Decreased serum glutathione with normal cysteine and homocysteine in patients with AIDS. Clin. Res. 38: 556A (abs.).
15. Kang, S.-S., Wong, P. W. K. & Malinow, M. R. (1992) Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu. Rev. Nutr. 12: 279-298.
16. Mansoor, A. M., Bergmark, C., Svardal, A. M., Lønning, P. E. & Ueland, P. M. (1995) Redox status and protein-binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Arterioscler. Thromb. Vasc. Biol. 15: 232-240.
17. Mansoor, M. A., Guttormsen, A. B., Fiskerstrand, T., Refsum, H., Ueland, P. M. & Svardal, A. M. (1993) Redox status and protein-binding of plasma aminothiols during the transient hyperhomocysteinemia following homocysteine administration. Clin. Chem. 39: 980-985.
18. Mansoor, M. A., Svardal, A. M., Schneede, J. & Ueland, P. M. (1992a) Dynamic relation between reduced, oxidized and protein-bound homocysteine and other thiol components in plasma during methionine loading in healthy men. Clin. Chem. 38: 1316-1321.
19. Mansoor, M. A., Svardal, A. M. & Ueland, P. M. (1992b) Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine and glutathione in human plasma. Anal Biochem. 200: 218-229.
20. Mansoor, M. A., Ueland, P. M., Aarsland, A. & Svardal, A. M. (1993) Redox status and protein binding of plasma homocysteine and other aminothiols in patients with homocystinuria. Metabolism 42: 1481-1485.
21. Mansoor, M. A., Ueland, P. M. & Svardal, A. M. (1994) Redox status and protein binding of plasma homocysteine and other aminothiols in patients with hyperhomocysteinemia due to cobalamin deficiency. Am. J. Clin. Nutr. 59: 631-635.
22. Müller, F., Svardal, A. M., Aukrust, P., Berge, R. K., Ueland, P. M. & Frøland, S. S. (1996) Elevated plasma concentration of reduced homocysteine in human immunodeficiency virus infection, Am. J. Clin. Nutr. (in press).
23. Staal, F. J. T., Ela, S. W., Roederer, M., Anderson, M. T., Herzenberg, L. A. & Herzenberg, L. A. (1992) Glutathione deficiency and human immunodeficiency virus infection. Lancet 339: 909-912.
24. Ueland, P. M. (1995) Homocysteine species as components of plasma redox thiol status. Clin. Chem. 41: 340-342.
25. Ueland, P. M., Refsum, H. & Brattström, L. (1992) Plasma homocysteine and cardiovascular disease. In: Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function (Francis, R. B Jr., ed.), pp. 183-236. Marcel Dekker, New York, NY.
26. Ueland, P. M., Refsum, H., Stabler, S. P., Malinow, M. R., Andersson. A. & Allen, R. H. (1993) Total homocysteine in plasma or serum Methods and clinical applications. Clin. Chem. 39: 1764-1779.
27. van Poppel, G., Kardinal, A., Princen, H. & Kok, F. J. (1994) Antioxidants and coronary heart disease. Ann. Med. 26: 429-434.
28. Witztum, J L. (1994) The oxidation hypothesis of atherosclerosis Lancet 344: 793-795.